What is Zim Laboratories Ltd. Quarterly Revenue?

Zim Laboratories Ltd. Quarterly Revenue Zim Laboratories Jun-2026 Quarterly Revenue is Rs 94 Cr which is growth of 29.0% YoY.

What is Zim Laboratories Ltd. Quarterly Net Profit?

Zim Laboratories Ltd. Quarterly Net Profit Zim Laboratories Jun-2026 Quarterly Net Profit is Rs -4 Cr which is growth of -129.1% YoY.

What is Zim Laboratories Ltd. Annual Revenue?

Zim Laboratories Ltd. Annual Revenue Zim Laboratories Mar-2026 Annual Revenue is Rs 382 Cr which is growth of 0.2% YoY.

What is Zim Laboratories Ltd. Annual Net Profit?

Zim Laboratories Ltd. Annual Net Profit Zim Laboratories Mar-2026 Annual Net Profit is Rs 6 Cr which is growth of -49.2% YoY.

What is Zim Laboratories Ltd. Total Shareholders Fund?

Zim Laboratories Ltd. Total Shareholders Fund Zim Laboratories Mar-2026 Total Shareholders Fund is Rs 286 Cr which is growth of 17.1% YoY.

What is Zim Laboratories Ltd. Total Assets?

Zim Laboratories Ltd. Total Assets Zim Laboratories Mar-2026 Total Assets is Rs 525 Cr which is growth of 13.1% YoY.

What is Zim Laboratories Ltd. Book Value Per Share?

Zim Laboratories Ltd. Book Value Per Share Zim Laboratories Mar-2026 Book Value Per Share is 54 Rs which is growth of 6.7% YoY.

What is Zim Laboratories Ltd. ROE?

Zim Laboratories Ltd. ROE Zim Laboratories Mar-2026 ROE is 2% which is growth of 2.7% YoY.

What is Zim Laboratories Ltd. Cash From Operating Activity?

Zim Laboratories Ltd. Cash From Operating Activity Zim Laboratories Mar-2026 Cash From Operating Activity is Rs 48 Cr which is growth of -5.8% YoY.

What is Zim Laboratories Ltd. Net Cash Flow?

Zim Laboratories Ltd. Net Cash Flow Zim Laboratories Mar-2026 Net Cash Flow is Rs 18 Cr which is growth of 9616.5% YoY.

Zim Laboratories Ltd.

NSE: ZIMLAB | BSE: 541400

Strong Performer, Getting Expensive

Download real time

-0.24(-0.18%)

125.19% Gain from 52W Low

125.9K

NSE+BSE Volume

NSE 23 Sep, 2026 3:53 PM (IST)

Portfolio

Alert

My Notes

Zim Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Zim Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Zim Laboratories Jun-2026 Quarterly Revenue is Rs 94 Cr which is growth of 29.0% YoY.
NEGATIVE
Quarterly Net Profit Zim Laboratories Jun-2026 Quarterly Net Profit is Rs -4 Cr which is growth of -129.1% YoY.

Zim Laboratories Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	94	109	109.5	90.4	72.9	110.1	97.2	91	83	118.9	96.9	86.7	67.6
SR_Q Operating Rev.	93.1	102.9	107.8	88.4	71.4	108.5	95.4	89.7	82	117.4	95.8	85.3	67
OI_Q Other Income	1	6.2	1.7	2	1.5	1.6	1.8	1.3	1	1.5	1.1	1.4	0.6
OEXPNS_Q Operating Exp.	90.6	96.3	95.3	82.2	67.1	93.3	83.6	81.3	74.1	102	84.6	76.3	62.5
OEXPNS_Q Operating Exp.	90.6	96.3	95.3	82.2	67.1	93.3	83.6	81.3	74.1	102	84.6	76.3	62.5
OP_Q Operating Profit	2.4	6.6	12.5	6.2	4.3	15.2	11.8	8.4	7.9	15.4	11.2	9	4.5
OPMPCT_Q Operating Profit Margin %	2.59%	6.40%	11.59%	6.98%	6.07%	14.04%	12.33%	9.35%	9.61%	13.14%	11.67%	10.51%	6.77%
DEP_Q Depr.	5.2	4.9	4.9	4.8	4.8	5.2	4.8	5	4.9	3.9	3.6	3.7	3.7
INT_Q Interest	3.6	3.3	3.4	3.2	3.3	2.9	2.7	2.9	2.9	2.3	1.7	1.2	1.7
PBT_Q Profit Before Tax	-5.4	4.5	5.9	0.2	-2.3	8.7	6	1.9	1.1	10.8	7	5.5	-0.2
TAX_Q Tax	-1.6	1.2	1.7	0.1	-0.6	3.2	1.7	0.6	0.3	2.9	2.2	1.3	-0.1
NP_Q Net Profit	-3.9	3.3	4.3	0.1	-1.7	5.4	4.4	1.2	0.8	7.9	4.8	4.2	-0.1
EPS_adj_Q EPS Adj. latest	-0.7	0.6	0.8	0	-0.3	1	0.8	0.2	0.1	1.5	0.9	0.8	-0
NP_TTM Net profit TTM	3.8	6	8.1	8.2	9.3	11.7	14.2	14.7	17.7	16.8	16	17.8	19.2
EPS_TTM Basic EPS TTM	0.7	1.1	1.7	1.7	1.9	2.4	2.9	3	3.6	3.4	3.3	3.6	4
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes		Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Zim Laboratories competitor comparison and performance snapshot within industry

Zim Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Zim Laboratories Mar-2026 Annual Revenue is Rs 382 Cr which is growth of 0.2% YoY.
NEGATIVE
Annual Net Profit Zim Laboratories Mar-2026 Annual Net Profit is Rs 6 Cr which is growth of -49.2% YoY.

Zim Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	-1.8%	4.5%	403	381.9	381.3	370.2	403	334	306.1	279	333.8	275.3	239.9	272.2
TotalOperatingRevenues_A Operating Rev. Ann.	-2.2%	4.1%	392.1	370.5	375.6	365.5	396.5	329.5	303.6	274.3	331.7	271.9	235	268.3
OI_A Other Income Ann.	21.2%	35.5%	10.9	11.4	5.6	4.7	6.4	4.5	2.5	4.7	2.1	3.4	4.9	3.9
OEXPNS_A Operating Exp. Ann.	-0.4%	5%	364.5	340.9	332.4	325.4	345.3	291.6	266.8	254.5	289.3	237.9	203.5	239
OEXPNS_A Operating Exp. Ann.	-0.4%	5%	364.5	340.9	332.4	325.4	345.3	291.6	266.8	254.5	289.3	237.9	203.5	239
OP_A Operating Profit Ann.	-16.7%	-4.3%	27.7	29.6	43.3	40.1	51.2	37.9	36.8	19.8	42.4	34	31.6	29.2
OPMPCT_A OPM Ann. %	-15.2%	-8.4%		7.75%	11.35%	10.83%	12.70%	11.36%	12.03%	7.09%	12.71%	12.34%	13.16%	10.74%
TotalExpenses_A Total Exp. Ann. ⌄	0.6%	5%		373.5	363.6	347.1	367	314.7	292.3	280.5	311	257.1	222.3	261.5
OtherExpenses_A Other Exp. Ann.	5.2%	9.6%	125.8	116.3	108.1	103.1	100	92.6	73.7	60.8	81.7	56.2	50.5	51.1
EmployeeBenefitExpenses_A Employee Exp. Ann.	8.9%	11.7%	64.7	60.1	56.4	50.8	46.5	38.6	34.5	50.6	48.1	40.8	33	30.7
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	-10.7%	0.9%		41	48.9	44.8	57.6	42.4	39.3	24.4	44.5	37.4	36.4	33.2
EBIDTPCT_A EBITDA Ann. margin %	-9.1%	-3.5%		10.73%	12.82%	12.10%	14.30%	12.71%	12.83%	8.76%	13.32%	13.58%	15.18%	12.18%
INT_A Interest Ann.	33.1%	3.9%	13.5	13.2	11.4	6.9	5.6	8.3	10.9	12.7	10.6	9.3	9.8	13.7
DEP_A Depr.	6.4%	5.8%	19.7	19.4	19.9	14.8	16.1	14.8	14.6	13.3	11.1	9.8	9	8.8
PBT_A PBT Ann.	-38.4%	-0.5%	5.3	8.4	17.6	23	35.9	19.3	8.6	-1.5	22.7	24.1	17.6	5.4
TAX_A Tax Ann.	-39.6%	-4.4%	1.5	2.4	5.9	6.3	10.9	6.3	3	-3.2	6.7	5.8	-1.1	0.3
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-37.9%	1.4%		6	11.7	16.8	25	13	5.6	1.7	16	18.3	18.7	5.2
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-37.9%	1.4%	3.8	6	11.7	16.8	25	13	5.6	1.7	16	18.3	18.7	5.2
NETPCT_A NPM Ann. %	-36.5%	-2.6%		1.61%	3.12%	4.58%	6.30%	3.94%	1.84%	0.63%	4.82%	6.72%	7.94%	1.91%
EPS_adj_A EPS Adj. latest Ann.	-38.4%	0%		1.1	2.2	3.1	4.7	2.4	1.1	0.3	3	3.4	3.5	1
result_notes Result Notes				Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

0.2%

2Y CAGR

1.6%

3Y CAGR

-1.8%

5Y CAGR

4.5%

7Y CAGR

1.9%

10Y CAGR

3.4%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

-48.7%

2Y CAGR

-40.2%

3Y CAGR

-37.9%

5Y CAGR

1.4%

7Y CAGR

-13.1%

10Y CAGR

1.4%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

2.6%

2Y CAGR

2.4%

3Y CAGR

-0.4%

5Y CAGR

7Y CAGR

2.4%

10Y CAGR

3.6%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Zim Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Zim Laboratories Mar-2026 Total Shareholders Fund is Rs 286 Cr which is growth of 17.1% YoY.
POSITIVE
Total Assets Zim Laboratories Mar-2026 Total Assets is Rs 525 Cr which is growth of 13.1% YoY.

Zim Laboratories Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	13.8%	12.8%	286.4	244.5	232	194.2	170.1	157.1	151.8	151.2	136	118.5	99.1
EQCAP_A Equity Share Capital Ann.	3.2%	27%	53.5	48.7	48.7	48.7	16.2	16.2	16.2	16.1	8.1	8	8
TotalShareCapital_A Total Share Capital Ann.	3.2%	27%	53.5	48.7	48.7	48.7	16.2	16.2	16.2	16.1	8.1	8	8
ReservesAndSurplus_A Reserves Plus Surplus Ann.	17%	10.6%	232.9	194.4	183.2	145.5	153.9	140.8	135.6	133.9	127.3	110.5	91.1
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	17%	10.6%	232.9	194.4	183.2	145.5	153.9	140.8	135.6	133.9	127.3	110.5	91.1
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	20.1%	19.1%	52.8	53.7	48.7	30.5	20	22	28.1	22.2	20.3	27.5	34.8
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	29.4%	-	10.4	11.3	10.1	4.8	0.4
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-7.2%	32%	0.8	2.1	3	1	0.7	0.2	0.6
CL_A Total Current Liabilities Ann. ⌄	19.1%	5.7%	186	166.2	161.9	110.2	145.3	141.2	143.1	151.5	141.2	113.1	122.4
TradePayables_A Trade Payables Ann.	8.9%	3.3%	76.6	71.9	62.7	59.3	81.9	65.1	65.9	72	66.3	45.1	47
OtherCurrentLiabilities_A Other Current Liabilities Ann.	20.9%	-2.1%	27.2	21.8	27.7	15.4	30.4	30.2	26.4	38.7	24.9	21.1	16.6
ShortTermProvisions_A ST Provisions Ann.	14.5%	-8.5%	0.9	0.7	0.8	0.6	0.7	1.4	1.1	0.7	0.4	0.2	2.5
TL_A Total Capital Plus Liabilities Ann.	16.2%	10.4%	525.2	464.4	442.5	334.9	335.4	320.3	322.9	324.9	297.4	259.1	256.2
FixedAssets_A Fixed Assets Ann. ⌄	23.2%	17%	249.5	229.3	200.7	133.4	114.7	113.6	120.9	114.1	102.5	92.6	95.1
TangibleAssets_A Tangible Assets Ann.	14.7%	9.2%	156.4	158.3	156.9	103.7	101.7	100.7	107.4	99.4	92.9	87.5	90.7
IntangibleAssets_A Intangible Assets Ann.	2.8%	8.7%	3.8	5.3	3.6	3.5	1.6	2.5	3.8	1.3	1.2	1.3	1.5
CapitalWorkInProgress_A Capital Work In Progress Ann.	48.9%	66.5%	58.8	44.1	23.5	17.8	5.1	4.6	4.7	7.8	4.8	2.7	2.9
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	20.4%	14.7%	272.8	248	224.8	156.2	134.8	137.3	146.6	133.6	125.4	105.3	102.1
NonCurrentInvestments_A Non Current Investments Ann.	29.2%	16.9%	17.7	13	8.2	8.2	8.2	8.1	8.1	4.5	0.1	0.1	0.1
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-						2.5	5.3	2.1	3.7	9.4
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-											6.4
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-27.3%	-15.6%	5.6	5.7	15.8	14.6	11.9	13.1	12.3	12.9	19.2	3.2	0.5
CA_A Total Current Assets Ann. ⌄	12.2%	6.6%	252.4	216.4	217.7	178.6	200.6	183	176.3	191.3	172.1	153.7	154.1
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	1.4%	7.6%	92.3	93.7	100.1	88.4	80.9	64	63.3	90.4	88.3	88.2	88.5
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	156.2%	36.2%	37	0.8	0.8	2.2	2.1	7.9	2.8	2.8	3.5	5.6	6.4
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-				0.1	0	0.1	0.2	0.3	0.1	0.1	20.9
OtherCurrentAssets_A Other Current Assets Ann.	-5%	-12.3%	29.4	35.4	35.6	34.3	42.3	56.7	53.6	42.8	28.5	24.4	0.6
TA_A Total Assets Ann.	16.2%	10.4%	525.2	464.4	442.5	334.9	335.4	320.3	322.9	324.9	297.4	259.1	256.2
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-12.5%	24.3%	21.1	15.7	19.4	31.5	7.9	7.1	7.9	8.2	8.5	8.4	3.9
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	38%	40.5	40.5	40.5	40.5	8.1	8.1	8.1	8.1
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	461.5%	181.6%	17.7	13		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

13.1%

2Y CAGR

8.9%

3Y CAGR

16.2%

5Y CAGR

10.4%

7Y CAGR

7.1%

10Y CAGR

7.4%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

11.9%

2Y CAGR

7.2%

3Y CAGR

19.1%

5Y CAGR

5.7%

7Y CAGR

10Y CAGR

4.3%

Total Current Liabilities Annual Cr growth is stable compared to historical averages.

Total ShareHolders Funds Ann.

1Y CHG

17.1%

2Y CAGR

11.1%

3Y CAGR

13.8%

5Y CAGR

12.8%

7Y CAGR

9.6%

10Y CAGR

11.2%

Total ShareHolders Funds Annual growth is higher than historical averages.

Zim Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Zim Laboratories Mar-2026 Book Value Per Share is 54 Rs which is growth of 6.7% YoY.
POSITIVE
ROE Zim Laboratories Mar-2026 ROE is 2% which is growth of 2.7% YoY.

Zim Laboratories Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	10.3%	-11.2%	53.5	50.2	47.6	39.9	104.7	96.7	93.8	93.8	168.7	147.6	123.8
ROA_A RoA Ann. %	-46.7%	-8.4%	1.13%	2.52%	3.78%	7.46%	3.87%	1.75%	0.53%	4.92%	6.14%	7.20%	2.00%
ROE_A ROE Ann. %	-45.5%	-10.2%	2.08%	4.80%	7.22%	12.87%	7.64%	3.57%	1.14%	10.58%	13.45%	15.75%	5.19%
ROCE_A ROCE Ann. %	-29.9%	-14.3%	6.36%	9.72%	10.67%	18.47%	14.51%	13.76%	6.21%	19.22%	17.66%	18.76%	18.23%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-8.7%	-3.1%	11.05%	13.01%	12.25%	14.53%	12.88%	12.93%	8.90%	13.40%	13.74%	15.49%	12.35%
PBITMargin_A EBIT Ann. Margin %	-17.7%	-6.4%	5.83%	7.71%	8.19%	10.46%	8.37%	8.11%	4.07%	10.04%	10.14%	11.65%	9.09%
PBTMargin_A PBT Ann. Margin %	-37%	-4.3%	2.26%	4.68%	6.30%	9.05%	5.85%	2.82%	-0.54%	6.85%	8.86%	7.48%	2.01%
NETPCT_A NPM Ann. %	-36.5%	-2.6%	1.61%	3.12%	4.58%	6.30%	3.94%	1.84%	0.63%	4.82%	6.72%	7.94%	1.91%
ASETTO_A Asset Turnover Ann. %	-12.6%	-2.3%	0.8	0.8	0.9	1.2	1	0.9	0.9	1.1	1	0.9	1
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-4.4%	1.5%	1.4	1.3	1.3	1.6	1.4	1.3	1.2	1.3	1.2	1.4	1.3
QuickRatio_A Quick Ratio Ann.	-6.5%	0%	0.9	0.8	0.8	1.1	0.9	0.9	0.8	0.9	0.9	1.1	1
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-							1.5	0.2		-	-
EarningRetention_A Earning Retention Ann. %	-	-								94.97%	95.61%	95.72%	84.46%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-								97.04%	97.15%	97.12%	94.25%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-								97.04%	97.15%	97.12%	94.25%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-0.3%	18.2%	406.3	502.1	570.9	410.1	308.7	176.3	164.8	261.3
EVPerNetSales_A EV Per Net Sales Ann.	3.2%	12.9%	1.1	1.3	1.6	1	0.9	0.6	0.6	0.8	-	-	-
PBV_A Price To Book Value Adjusted	-9.3%	12.6%	2.5	2.66	2.81	3.35	1.28	1.38	1.42	1.42	0.79	0.9	1.08
EVPerEBITDA_A EV Per EBITDA Ann.	11.7%	17.1%	9.9	10.3	12.8	7.1	7.3	4.5	6.7	5.9	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	0%	17.6%	0.9	1	1.3	0.9	0.8	0.4	0.3	0.6	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-	-								94.96%	95.60%	95.71%	84.45%
EYield_A Earnings Yield Ann.	-	-	0	0	0	0.1	0.1	0.1	0	0.1
DEBT_CE_A Total Debt to Total Equity Ann.	10.1%	0%	0.4	0.5	0.5	0.3	0.3	0.4	0.5	0.4	0.5	0.6	0.9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-56.7%

2Y CAGR

-46.3%

3Y CAGR

-45.5%

5Y CAGR

-10.2%

7Y CAGR

-20.7%

10Y CAGR

-8.7%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-55.2%

2Y CAGR

-45.3%

3Y CAGR

-46.7%

5Y CAGR

-8.4%

7Y CAGR

-19%

10Y CAGR

-5.5%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

7.7%

2Y CAGR

3.8%

3Y CAGR

-4.4%

5Y CAGR

1.5%

7Y CAGR

1.1%

10Y CAGR

0.7%

Current Ratio Annual growth is higher than historical averages.

Zim Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Zim Laboratories Mar-2026 Cash From Operating Activity is Rs 48 Cr which is growth of -5.8% YoY.
POSITIVE
Net Cash Flow Zim Laboratories Mar-2026 Net Cash Flow is Rs 18 Cr which is growth of 9616.5% YoY.

Zim Laboratories Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	10.7%	8.4%	47.7	50.6	11.5	35.2	47	31.9	21.3	37.1	36.7	32.1	22.1
PBT_A PBT Ann.	-38.4%	-0.5%	8.4	17.6	23	35.9	19.3	8.6	-1.5	22.7	24.1	17.6	5.4
INT_A Interest Ann.	33.1%	3.9%	13.2	11.4	6.9	5.6	8.3	10.9	12.7	10.6	9.3	9.8	13.7
TAX_A Tax Ann.	-39.6%	-4.4%	2.4	5.9	6.3	10.9	6.3	3	-3.2	6.7	5.8	-1.1	0.3
CFI_A Cash from Investing Act. Ann.	-	-	-57.4	-41.3	-71.9	-35.2	-14.4	-5.7	-18.5	-23	-25.8	-7.2	-11.7
CFA_A Cash from Financing Act. Ann.	260.9%	-	28.2	-9.1	59.5	0.6	-33	-26	-2.5	-15.2	-9.8	-25.2	-10.4
NCF_A Net Cash Flow Ann. ⌄	213%	147%	18.4	0.2	-0.9	0.6	-0.4	0.2	0.3	-1.1	1.1	-0.3	-0
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-7.2%	-10.6%	0.4	0.2	1.1	0.5	0.9	0.7	0.4	1.5	0.4	0.7	0.7
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	157.6%	83.6%	18.8	0.4	0.2	1.1	0.5	0.9	0.7	0.4	1.5	0.4	0.7

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-5.7%

2Y CAGR

103.7%

3Y CAGR

10.7%

5Y CAGR

8.4%

7Y CAGR

3.7%

10Y CAGR

Cash from Operating Activity Annual is falling faster than historical averages.

Cash from Financing Act. Ann.

2Y CAGR

-31.2%

3Y CAGR

260.9%

Cash from Financing Annual Activity growth is higher than historical averages.

Zim Laboratories investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

125.19% Gain from 52W Low

Zim Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents